Changes and disruptions in diagnosis, treatment and follow-up of breast cancer during two periods of the COVID-19 pandemic in Turkey
Sertaç Ata Güler, Özlem Özkan Güler, Turgay Şimşek, Nuh Zafer Cantürk
Similar Articles
Is there an increasing trend of risk-reducing prophylactic mastectomy procedure in preventing breast cancer among women?
Bilal Arslan, Deniz Tazeoğlu, Ahmet Dağ, Mustafa Berkeşoğlu, Asena Ayça Özdemir
The role of bioimpedance spectroscopy method in severity and stages of breast cancer-related lymphedema
Türkan Turgay, Tuba Denkçeken, Göktürk Maralcan
Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging
Jan Žatecký, Oldřich Coufal, Miloš Holánek, Otakar Kubala, Markéta Kepičová, Jiří Gatěk, Milan Lerch, Matúš Peteja
Long-term results of breast cancer patients who received IOERT as boost during BCS: A single-institution retrospective analysis
Semra Günay, Berk Gökçek, Özge Kandemir, Arzu Akan, Orhan Yalçın
Frequency of axillary nodal complete pathological response of breast cancer patients in neoadjuvant chemotherapy setting: A cross-sectional study
Syeda Sakina Abidi, Lubna Vohra, Asad Ali Kerawala, Annam Kafeel, Muhammad Umair Tahseen, Saad Javed
Evaluation of breast cancer awareness in female patients diagnosed with schizophrenia
Ayşe Gökçen Gündoğmuş, Yasemin Koçyiğit, Şerif Bora Nazlı
The effect of surgery and hormone therapy on quality of life in breast cancer patients receiving radiotherapy
Yasemin Benderli Cihan, Orhun Öztürk
Utility of positron emission tomography for determination of axillary metastasis of breast cancer
Gökhan Pösteki, Alican Güreşin, Sertaç Ata Güler , Turgay Şimşek, Nuh Zafer Cantürk
Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study
Adnan Gündoğdu, Mehmet Uluşahin, Arif Burak Çekiç, Seher Nazlı Kazaz, Ali Güner
Journal Metrics
| 2020 | 2021 | 2022 | |
| SCImago Journal Rank | 0.216 | 0.180 | 0.218 |
| CiteScore (Scopus) | 1.0 | 1.1 | 1.1 |
| CiteScore Rank (Scopus) | #279/422 | #291/469 | #312/495 |
| Journal Citation Indicator (Clarivate) | 234/271 (Q4) | 227/279 (Q4) | 230/286 (Q4) |
